Remove Cardiology Remove Development Remove Doctors Remove Research
article thumbnail

AI supports doctors' hard decisions on cardiac arrest

Medical Xpress

When patients receive care after cardiac arrest, doctors can now—by entering patient data in a web-based app—find out how thousands of similar patients have fared.

Doctors 75
article thumbnail

Velocity Clinical Research Expands to Poland

Velocity Clinical Research

Velocity Clinical Research, the leading multi-specialty clinical sites business, announced it has expanded into Poland, acquiring its first site, ClinMedica Research. The site is recognized as one of the best research facilities in the country by Sponsors and contract research organizations (CROs).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pediatric heart transplant method developed by U of A doctors allows for more surgeries, better outcomes: Study

Scienmag

Blood type-incompatible heart transplant surgery for infants under the age of two pioneered in Canada, now used worldwide Credit: Lindsey Kemp A pediatric heart transplant procedure pioneered by Canadian doctors–once deemed impossible–has been shown to be at least as effective as the traditional approach, according to newly published research (..)

Doctors 52
article thumbnail

Artificial intelligence could improve heart attack diagnosis to reduce pressure on emergency departments

Medical Xpress

An algorithm developed using artificial intelligence could soon be used by doctors to diagnose heart attacks with better speed and accuracy than ever before, according to new research from the University of Edinburgh published in Nature Medicine.

Doctors 98
article thumbnail

Merck Announces Retirement of Dr. Roy D. Baynes; Dr. Eliav Barr Appointed Head of Global Clinical Development and Chief Medical Officer

The Pharma Data

Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), will be retiring from Merck in July. Li, president, Merck Research Laboratories, until his retirement. He also led the expansion of Merck’s research and development in China and Japan. “It

article thumbnail

Velocity Expands to 17 Sites in Europe

Velocity Clinical Research

The acquisition of KO-MED is Velocity’s first foray into Oncology research, which accounts for roughly 40-50% of clinical trials globally. KO-MED has been the leading multi-site network in Poland since 2020, having enrolled over 9,000 patients into clinical research.

article thumbnail

Disrupted medical conferences: Lessons learnt

pharmaphorum

The shift to virtual alone has already had a profound impact on all conference stakeholders: medical societies themselves, doctors, patients, commercial partners, and professional conference organisers (PCOs). Doctors want a choice. These order of magnitude increases were also reflected at national levels. yes; and 15.7%

Doctors 104